Tomas G Olsson (Former)
51 – 56 of 56
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule
- Contribution to journal › Article
-
Mark
Reduced postnatal cerebral glucose metabolism measured by PET after asphyxia in near term fetal lambs
- Contribution to journal › Article
-
Mark
Cerebral blood volume (CBV) in humans during normo- and hypocapnia: influence of nitrous oxide (N(2)O)
- Contribution to journal › Article
- 1999
-
Mark
Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas
- Contribution to journal › Article
- 1997
-
Mark
Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET
- Contribution to journal › Article
- 1996
-
Mark
A clinical positron emission tomography facility : 2-¹⁸FDG studies : development and results
(1996)
- Thesis › Doctoral thesis (compilation)
